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A B S T R A C T
Lipid droplets (LDs) are the main fat storing sites in almost all species from bacteria to humans. The perilipin
family has been found as LD proteins in mammals, Drosophila, and a couple of slime molds, but no bacterial LD
proteins containing sequence conservation were identiﬁed. In this study, we reported that the hydroxysteroid
dehydrogenase (HSD) family was found on LDs across all organisms by LD proteomic analysis. Imaging ex-
periments conﬁrmed LD targeting of three representative HSD proteins including ro01416 in RHA1, DHS-3 in C.
elegans, and 17β-HSD11 in human cells. In C. elegans, 17β-HSD11 family proteins (DHS-3, DHS-4 and DHS-19)
were localized on LDs in distinct tissues. In intestinal cells of C. elegans, DHS-3 targeted to cytoplasmic LDs, while
DHS-9 labeled nuclear LDs. Furthermore, the N-terminal hydrophobic domains of 17β-HSD11 family were ne-
cessary for their targeting to LDs. Last, 17β-HSD11 family proteins induced LD aggregation, and deletion of DHS-
3 in C. elegans caused lipid decrease. Independent of their presumptive catalytic sites, 17β-HSD11 family proteins
regulated LD dynamics and lipid metabolism through aﬀecting the LD-associated ATGL, which was conserved
between C. elegans and humans. Together, these ﬁndings for HSDs provide a new insight not only into the
mechanistic studies of the dynamics and functions of LDs in multiple organisms, but also into understanding the
evolutionary history of the organelle.
1. Introduction
The excessive lipid storage in lipid droplets (LDs) is highly con-
nected to metabolic diseases including obesity, atherosclerosis, hepatic
steatosis, insulin resistance, and hyperlipidemia [1–3]. LDs are the in-
tracellular storage site for neutral lipids and have been found in almost
all eukaryotic cells, and some prokaryotic cells, such as Rhodococcus
[4–6]. All LDs share the same basic structure consisting of a hydophobic
core of neutral lipids (triacylglycerol (TAG) and sterol ester (CE)),
which is wrapped by a monolayer of phospholipids decorated by pro-
teins. The composition of neutral lipids, phospholipids and proteins
varies among organisms and tissues [7]. The lipids in LDs function as
metabolic substrates for energy production and as components for
membrane synthesis in cells [8].
Numerous studies have identiﬁed several resident proteins on the
LD surface [9–12]. These proteins are involved in lipid metabolism and
transport, membrane traﬃcking, and chaperone function [13–16]. The
protein composition varies among subpopulations of LDs within a cell,
or between LDs isolated from diﬀerent cell types. The best known ex-
amples of LD resident proteins are the perilipins. They have been pro-
posed to serve structural roles on the LD surface and have been found to
regulate cellular lipid metabolism and play signiﬁcant roles in human
health [17,18]. Perilipins were ﬁrst identiﬁed in mammals. Their
homologs were subsequently found in Drosophila and a few slime molds
such as Dictyostelium based on sequence homology [17,19,20]. How-
ever, similar bioinformatic approaches failed to identify perilipin
homologs in other organisms including C. elegans, plants, yeast and
bacteria. This raises the question on the existence of evolutionarily
conserved LD proteins that are present from bacteria to humans.
Using newly developed techniques, LDs have been isolated from
many cell types and tissues of almost all model biological organisms
and analyzed by proteomic techniques [5,11,21,22]. These studies
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reveal that a large set of hydroxysteroid dehydrogenases (HSDs) is
targeted to LDs. HSDs, which belong to the superfamily of short-chain
dehydrogenases/reductases (SDRs) or aldo-ketoreductases (AKRs), are
important enzymes involved in lipid metabolism and especially in
steroid hormone metabolism. Evolutionarily, the SDR protein family is
ancient, and is found in all forms of life, including bacteria and archaea,
providing clues to their fundamental signiﬁcance in metabolic pro-
cesses [23–26]. This broadly conserved family may provide insight into
the evolution of LD as an organelle.
The mechanisms governing the targeting of LD proteins are still not
well understood. The subcellular localization of perilipins and other LD-
associated proteins varies between cell types and tissues and the LD
targeting pattern can diﬀer even within a cell [27,28]. In this study, we
enumerate LD targeting patterns, the cellular distribution and the cor-
relation of cellular distribution with functional signiﬁcances of HSDs.
In mammals, SDRs function as enzymatic switches controlling the
balance between active and inactive steroid hormones. By binding to
speciﬁc receptors, steroids exert transcriptional control over numerous
genes that regulate physiological processes including cell signaling,
growth, reproduction, and energy homeostasis. For example, the SDR
enzymes RDH10 and DHRS3 contribute to the oxidation of retinol in the
retinoic acid biosynthetic pathway, thus playing an important role in
embryonic development [29,30]. Although these two proteins have
been found on LDs, the signiﬁcance of this localization to their func-
tions is not clear [31,32].
One typical class of SDRs, the 17β-hydroxysteroid dehydrogenases
(17β-HSDs), catalyzes the oxidation or reduction at position 17 in the D
ring of steroids, and is primarily involved in estrogen and androgen
synthesis [33]. These hormones stimulate and control the development
and maintenance of female and male characteristics and other pro-
cesses. Besides their role in sex hormone formation, a few 17β-HSD
enzymes, such as 17β-HSD3 and 17β-HSD12, are involved in fatty acid
production and are essential for growth, reproduction and development
in C. elegans [34,35]. The role of LD resident 17β-HSDs in the in-
tegration of sex hormone synthesis and lipid metabolism requires fur-
ther investigation.
In the 1990s, it was reported that oral estrogen treatment was as-
sociated with increased body fat [36]. Subsequent evidence indicated
that estrogen depressed whole body lipid oxidation and increased
adiposity, possibly through regulation of carnitine palmitoyl-
transferase-1 (Cpt 1) expression [37,38]. The underlying mechanism
linking estrogenic regulation of lipid metabolism was thought to de-
pend on interactions of estrogen receptor signaling events involving
lipolytic and/or lipogenic enzyme activity, free fatty acid metabolism,
and adipokine production. For example, estrogen receptor alpha (ERα)
could regulate lipid metabolism in bone through ATGL and perilipin,
and ACSL4 was a target of 17β-estradiol-stimulated ERα and was re-
quired for the cellular uptake of exogenous PUFA in ERα positive breast
carcinoma cells [39–41]. These ﬁndings raise the question: whether LD
associated HSDs are involved in the formation of estrogen, androgen or
other steroid hormones which subsequently regulate lipid metabolism
and other cellular processes. For example, 17β-HSD13 was identiﬁed as
a liver-speciﬁc LD-associated protein which contributed to the patho-
genesis of nonalcoholic fatty liver disease (NAFLD) by an unknown
mechanism [12,42].
In this study, we report deep conservation of LD targeting by HSD
proteins in diﬀerent organisms, and diﬀerent tissues and distributions
in the intestinal cells of C. elegans. In addition, C. elegans DHS-3 and its
mammalian ortholog 17β-HSD11 regulate LD size, LD distribution and
TAG content similar to that seen with ATGL, but in a manner in-
dependent of their putative catalytic sites. These data indicate that the
signiﬁcance of HSDs, a conserved LD protein family.
2. Materials and methods
2.1. Plasmids, strains and culture conditions
The bacterial Rhodococcus sp. RHA1 (RHA1) strain was used as wild
type and for genetic mutants. The transgenic RHA1 bacteria used in this
study are listed (Table S1). The ro01416 gene deletion mutant was
constructed as described in a previous study [5]. Cells of RHA1 were
cultivated aerobically in LB at 30 °C. Then 1ml of cells (OD600= 2.0)
was collected by centrifugation and then cultured in 10ml mineral salt
medium (MSM) with 0.5 g/l NH4Cl and 10 g/l sodium gluconate until
reaching OD600= 2.0–2.5. The culture conditions were as described
previously [5,43].
The N2 Bristol strain of C. elegans was used as wild type in this
study. The genetic mutants, transgenic worms and RNAi bacteria strains
used are listed (Table S1). Nematode growth media was used to
maintain C. elegans with the E. coli strain (OP50) as food at 20 °C.
HeLa cells were cultured in DMEM (Macgene Biotech., Beijing, CN)
supplemented with 10% FBS (Hyclone), 100 U/ml penicillin and
100mg/ml streptomycin (Macgene Biotech., Beijing, CN) at 37 °C with
5% CO2. Sodium oleate (OA) (Sigma-Aldrich) was prepared as de-
scribed previously [44]. Cells were treated with OA (+OA) in culture
medium and absolute ethanol was used as vehicle control. Transgenic
cells are listed (Table S1).
All the plasmids used in this study are also listed in Table S1.
Plasmid pGEX-6P-2 and pET28a-SMT3 were used for protein expression
in E. coli, pJAM2 for protein expression in RHA1, pK18mobsacB for
gene knockout in RHA1, pPD95.79 and pPD49.26 for protein expres-
sion in C. elegans, and pEGFP-N1 and pQCXIP for protein expression in
HeLa cells.
2.2. Staining and image analysis
Cultured RHA1 cells were collected and washed twice with PBS.
Then cells were applied to glass coverslips pretreated with poly-L-lysine
(PB0589) and dried for 30min. The coverslips were washed three times
with 1ml PBS and were incubated with LipidTOX red (diluted 1:500 in
PBS), protected from light, for 30min. The stained samples were
mounted on glass slides using mounting media (P0126) and were vi-
sualized with an Olympus FV1000 confocal microscope.
L4 worms were washed oﬀ growth plates and were washed three
times with PBS. Then worms were ﬁxed in 4% paraformaldehyde for
30min. Fixed worms were washed three times, and stained with
LipidTOX red (1:1000). Worms were laid on a 6% agar plate, washed
three times and were visualized by confocal microscopy.
HeLa cells on glass coverslips were ﬁxed in 4% paraformaldehyde
for 30min and were washed three times with PBS. LDs and nuclei were
stained separately by LipidTOX red and Hoechst for 30min protected
from light. The stained cells were washed three times, mounted with
Mowiol mounting media and were then examined by confocal micro-
scopy.
2.3. Isolation of lipid droplets and protein preparation for Western blotting
Cultured RHA1 and HeLa cells were collected and fractionated as
described previously [5,45]. Worms were washed and fractionated as
described previously [11].
The proteins in diﬀerent fractions were separated on 10% SDS-
PAGE gels followed by silver staining or Western blotting. Polyclonal
antibodies for DHS-3 and MDT-28/PLIN-1 were prepared by AbMax
Biotechnology Co., Ltd. The anti-GFP (IMA1006L, IMAGEN), anti-GST
(IMA1002L, IMAGEN), anti-Actin (HX1827, Hua Xin Bo Chuang), anti-
GAPDH (MAB374, Millipore), anti-ATGL (2138 s, Cell Signaling), anti-
PLIN2 (610,102, Progen) and anti-17β-HSD11 (ab136109, Abcam)
were purchased.
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2.4. Expression and puriﬁcation of proteins
Standard molecular cloning techniques were used. Ro01416 and
DHS-3 were cloned into the pGEX-6 P-2 expression vector and were
expressed with an N-terminal GST tag. GFP and 17β-HSD11 was cloned
into the pET28a-SMT3 expression vector and was expressed with an N-
terminal 6×His tag and SMT3 domain.
All of the proteins were expressed in Rosetta E. coli in LB media. The
cells were grown to an OD600 of 0.6 and were induced with 0.4mM
isopropyl β-D-1-thiogalactopyranoside (IPTG) at 16 °C for 24 h. The
cells were collected by centrifugation at 4000 g for 20min. Then the
cells expressing GST-ro01416 and GST-DHS-3 were resuspended in
50mM Tris-HCl, 150mM NaCl, 1 mM EDTA, 1mM DTT and 4%
Glycerol (pH 7.4) while the cells expressing HIS-SMT3-17β-HSD11 and
HIS-SMT3-GFP were resuspended in 50mM Tris-HCl, 150mM NaCl
(pH 7.4). Cells were then lysed in a high-pressure cell press (JNBIO JN-
3000 PLUS) and the cell lysates were centrifuged at 16, 000 g for 1 h to
obtain clariﬁed supernatants. The supernatants containing soluble GST-
ro01416, GST-DHS-3 proteins were applied to GST aﬃnity chromato-
graphy resin (Glutathione sepharose 4B, GE), and the supernatants of
soluble HIS-SMT3-GFP and HIS-SMT3-17β-HSD11 protein were applied
to nickel aﬃnity chromatography resin (Chelating Sepharose Fast Flow,
Amersham Biosciences). The chromatographic puriﬁcations were
completed according to manufacturer's guidelines. The GSH and imi-
dazole used to elute the proteins were removed by buﬀer exchange
using Amicon centrifugal concentrators (Millipore). The GFP and 17β-
HSD11 proteins were obtained from the cleavage of HIS-SMT3-GFP and
HIS-SMT3-17β-HSD11 by SUMO protease ULP1. The purity of the
proteins was detected by SDS–PAGE.
2.5. Construction of adiposomes and recruitment of proteins to adiposomes
The construction of adiposomes and the experiments involving the
recruitment of proteins to adiposomes were conducted as described
previously [46]. 1,2-Di (9Z-octadecenoyl)-sn-glycero-3-phosphocholine
(DOPC) was purchased from Avanti and the TAG used was extracted
from rat fat pads in the laboratory. Deﬁned quantities of puriﬁed pro-
teins were added to adiposomes to a ﬁnal volume of 60 μl. The mixture
was gently vortexed and then incubated at room temperature for 1 h.
The adiposomes were centrifuged at 15, 000 rpm for 5min and the
solution was removed for analysis. Equal amount of proteins, adipo-
somes and solutions were analyzed by SDS-PAGE.
2.6. Measurement of TAG and cholesterol ester (CE) levels
RHA1 cells, worms and HeLa cells were washed three times with
PBS, and were then dissolved in 200 μl 1% Triton X-100 with sonica-
tion. Whole cell lysates were centrifuged at 15, 000 rpm for 5min at
4 °C. The TAG and CE content of the supernatants were separately
measured using the Triglyceride Assay Kit and CHO Assay Kit (BioSino
Bio-Technology and Science Inc., China). The corresponding protein
concentration was quantiﬁed using a Pierce BCA Protein Assay Kit
(Thermo, USA).
2.7. Growth rate and fertility analysis
Eggs isolated from gravid adults using hypochlorite treatment were
hatched in M9 buﬀer overnight, and were then plated onto NGM plates.
The number of worms that reached adult stage was scored 2 days later.
Then, 5 L4 worms were transferred individually to fresh plates. Worms
were transferred daily until they did not produce any more progeny.
Two or three days after removal of the adult, the number of live pro-
geny was counted. Line charts and histograms were made with
Graphpad prism 5.
2.8. Quantitative RT-PCR analysis
Total RNA was isolated using Trizol reagent according to the
manufacturer's protocol. cDNA was synthesized using Moloney murine
leukemia virus (M-MuLV) reverse transcriptase with random hexamer
primers. RT-PCR was performed on a CFX96 real-time system with
SYBR green. Relative expression levels of all mRNAs were normalized
to ama-1 mRNA.
2.9. Statistical analyses
Data are presented as mean ± SEM unless otherwise indicated. The
statistical analyses were performed using GraphPad Prism 6 and Image
J (NIH, USA). Determination of signiﬁcance between groups was per-
formed using Student t-tests, or Two-way ANOVA as indicated.
3. Results
3.1. HSD proteins are present in the LD proteomes of almost all cell types
and organisms
There have been numerous studies examining the proteomes of LDs
from diverse cell types and tissues of organisms including bacteria,
green algae, yeast, plants, worms, insects, and mammals. HSD family
members have been identiﬁed on LDs in many of these studies as
summarized in Table 1 and Table S2. The variations in the nomen-
clature for HSD proteins are presented for reference in Table S3. The
SDR proteins that have been found in various LD proteomes are sum-
marized in Table S4.
3.2. 17β-HSD11 family proteins are localized on LDs from bacteria, C.
elegans and mammals
As shown in Table 1, 17β-HSD11 subfamily members are frequently
found on LDs. These proteins are highly conserved among bacteria,
yeast, worms, insects, mice, and humans as demonstrated by sequence
alignment (Fig. 1A). Here, we use Rhodococcus jostii RHA1, C. elegans
and HeLa cells to determine the localization of HSD proteins.
In bacteria, three HSD proteins, ro03952 (ortholog of 17β-HSD10),
ro06007 (ortholog of 17β-HSD11) and ro01416 (ortholog of 17β-
HSD12) were identiﬁed in LD proteomes (Table S2). To conﬁrm the
localization of these three proteins by an independent method, GFP
fusion proteins were expressed in RHA1. The transfected cells were
stained with LipidTOX red and were visualized by confocal microscopy.
The images showed no colocalization of LipidTOX with ro03952-GFP
and ro06007-GFP (data not shown), suggesting that these proteins are
not located on LDs, or that GFP disrupts their targeting. However,
ro01416-GFP was clearly colocalized with LDs (Fig. 1Ba). For further
conﬁrmation, the ro01416-GFP strain was fractionated by diﬀerential
centrifugation and the fractions were separated by SDS-PAGE. The
ro01416-GFP protein was found in the LD fraction as shown by Western
blotting (Fig. 1Bb). Therefore, ro01416 is localized to LDs in RHA1
while the other two family members are not.
In C. elegans, the protein DHS-3, the ortholog of 17β-HSD11, was
speciﬁcally localized on LDs as demonstrated by both morphological
and biochemical methods (Fig. 1Ba, Bb). This is in agreement with our
previous work [11,75]. When human 17β-HSD11-GFP was expressed in
HeLa cells, it also colocalized with LipidTOX signals (Fig. 1Ba). In ad-
dition, in untransfected HeLa cells, endogenous 17β-HSD11 was de-
tected in LDs by Western blotting (Fig. 1Bb), which was consistent with
previous ﬁndings [49,71].
To verify these results, additional in vitro experiments were con-
ducted. We have reported that recombinant LD-associated proteins
could be recruited to adiposomes constructed in vitro [46]. Re-
combinant GST-ro01416, GST-DHS-3 and 17β-HSD11 were expressed
in and puriﬁed from E. coli. These recombinant proteins were incubated
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with adiposomes, the mixture was centrifuged, and the solution con-
taining unbound proteins was removed (Fig. S1a). Fractions from the
separation were examined by silver staining and Western blotting.
These analyses demonstrated that ro01416 was partially targeted to the
adiposomes, and that DHS-3 and 17β-HSD11 localized to adiposomes
(Fig. S1b). This ﬁnding indicated that these three proteins could target
to LDs without interactions with any other proteins. Together, these
results reveal that 17β-HSDs in bacteria, C. elegans and mammals all
target to LDs (Fig. 1C).
3.3. DHS-3 and its paralogs, DHS-4 and DHS-19, are localized on LDs in
diﬀerent tissues in C. elegans
In C. elegans, the DHS family members DHS-3, DHS-4, DHS-9 and
DHS-19 were found in the LD proteome (Table. S2). Based on the small
phylogenetic tree, DHS-3, DHS-4 and DHS-19 are closely related, and
all of them are predicted to be orthologs of 17β-HSD11 (Fig. 2A and
Table. S5). To examine the cellular distribution and localization of DHS-
4 and DHS-19, transgenic dhs-4p::dhs-4::gfp and dhs-19p::dhs-19::gfp
animals were generated. The dhs-3p::dhs-3::gfp animals were generated
in our laboratory previously. The localizations of the GFP fusion pro-
teins were observed within the living animals using confocal micro-
scopy. DHS-3 (Fig. 2B, arrow) has been determined to be mainly lo-
calized on intestinal LDs [75]. Based on the morphology, DHS-4 was
detected in the hypodermis (Fig. 2B, arrows). DHS-19 was also in the
hypodermis, as well as possibly localized on LDs in the muscle (Fig. 2B,
arrows). In addition, DHS-4 and DHS-19 were present on ring-like
structures, typical for LD localized proteins. To further verify the LD
localization of these GFP fusion proteins, the previously identiﬁed LD
protein MDT-28/PLIN-1::mCherry was introduced to these three re-
porters and was visualized by confocal microscopy. All GFP signals
were observed to be colocalized with the mCherry signals (Fig. S2),
directly demonstrating their subcellular localization to LDs.
3.4. DHS-9::GFP labels nuclear LDs in C. elegans and Huh7 cells
DHS-9 is predicted to be an ortholog of DHRS1 (which has been
identiﬁed in a LD proteomics study), and is part of a subfamily of the
SDR superfamily (Table. S4). To examine the expression pattern and
cellular functions of DHS-9, DHS-9::GFP driven by its endogenous
promoter was constructed. We observed that the GFP tagged protein
was expressed in the intestine, and was found at high levels in the
nucleus and at lower levels in the cytosol (Fig. 2C). Besides the diﬀuse
GFP signals in the nucleus, additional GFP puncta were found in the
nucleoplasm of some, if not all, nuclei of intestinal cells (Fig. 2C). We
further examined the punctate structures by confocal microscopy. In-
terestingly, micrographs of confocal microscopy with airyscan clearly
showed clustered rings (Fig. 2D). Thus DHS-9 appears to form clustered
rings in nuclei.
To determine if the structures labeled by DHS-9 were nuclear LDs,
we examined whether the previously identiﬁed LD protein DHS-3 and
MDT-28/PLIN-1 could colocalize with DHS-9 in the nucleus. Thus, dhs-
9p::dhs-9::gfp; dhs-3p::dhs-3::mCherry, and dhs-9p::dhs-9::gfp; mdt-28/
plin-1p::mdt-28/plin-1::mCherry worms were constructed and examined
by confocal microscopy. The ﬂuorescence images showed no colocali-
zation of DHS-3::mCherry or MDT-28/PLIN-1::mCherry with DHS-
9::GFP in the nucleus (Fig. S3a, Fig. S3b). Instead, DHS-3 and MDT-28/
PLIN-1 were exclusively present on the cytoplasmic LDs. In another
experiment, MDT-28/PLIN-1 was expressed with a nuclear localization
signal to examine whether MDT-28/PLIN-1 colocalize with DHS-9 in
the nucleus. Transgenic animals expressing mdt-28/plin-1p::mdt-28/plin-
1::mCherry::NLS; dhs-9p::dhs-9::gfp worms were generated and we ob-
served MDT-28/PLIN-1::mCherry::NLS colocalized well with DHS-
9::GFP in the nucleus (Fig. 2E).
The DHS-9::GFP signal was also found in the cytosol (Fig. 2C).
However, the signal was very weak, which made observation of speciﬁc
LD targeting diﬃcult. Therefore, to verify whether DHS-9::GFP could
target to cytoplasmic LDs, LDs from dhs-9p::dhs-9::gfp worms were
puriﬁed and examined microscopically. GFP signal was found on the
puriﬁed LDs. In parallel, LDs from dhs-9p::dhs-9::gfp; mdt-28/plin-
1p::mdt-28/plin-1::mCherry worms were puriﬁed and the images also
showed GFP signal colocalized with mCherry signal (Fig. 2F, Fig. S3c),
suggesting DHS-9 could target to cytoplasmic LDs.
Nuclear LDs were observed previously in Huh7 cells [76].
Table 1
Summary of HSDs in LD proteomes.
Proteins LD types References
Organisms Tissues and cells
3β-HSD1 Mouse; human Intestine cells; steroidogenic cells [47–50]
3β-HSD2 / /
3β-HSD3 / /
3β-HSD4 Rat Liver [51]
3β-HSD5 Rat Liver [51]
3β-HSD6 / / /
3β-HSD7 Mouse; Rat Skeletal muscle (cells); Pancreatic β-cells [10,52]
11β-HSD1 Plants; mouse; human BAT; liver; [12,53–58]
11β-HSD2 / / /
11β-HSD3 / / /
17β-HSD1 Yeast [59,60]
17β-HSD2 Yeast; human Liver; intestine cells [12,48,61]
17β-HSD3 / / /
17β-HSD4 Mouse; rat; human BAT; liver; WAT; skeletal muscle (cells); hepatocytes; pancreatic β-cells [10,12,52,53,62,63]
17β-HSD5 / / /
17β-HSD6 Human Liver [12]
17β-HSD7 Yeast; Mouse; Rat; Human Liver; skeletal muscle (cells); adipocytes; epithelia; ﬁbroblasts; intestine cells;
macrophage; pancreatic β-cells; steroidogenic cells
[9,10,12,47,49,51,52,61,64–68]
17β-HSD8 Mouse BAT [53]
17β-HSD9 / / /
17β-HSD10 Bacteria; Insects; mouse BAT; steroidogenic cells [5,49,53,69]
17β-HSD11 Bacteria; worms; insects; mouse;
rat; human
Liver; skeletal muscle (cells); epithelia; ﬁbroblasts; hepatocytes; intestine cells;
steroidogenic cells
[4,9–12,21,47–49,65,70–74]
17β-HSD12 Worms; bacteria; mouse; human Liver; skeletal muscle cells [4,10–12]
17β-HSD13 Rat; human Liver [12,51]
17β-HSD14 Yeast [61]
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Therefore, DHS-9::GFP was transfected into Huh7 cells to investigate
whether the protein would target to nuclear LDs in mammalian cells.
Under standard culture conditions, the GFP signal was diﬀusely dis-
tributed. However, when the cells were treated with 200 μM OA, the
DHS-9::GFP partially colocalized with LipidTOX red staining in the
cytosol and nucleus (Fig. 2G), demonstrating that DHS-9 can be tar-
geted to mammalian LDs in both the cytosol and the nucleus. Similar
results were seen with DHRS1, the ortholog of DHS-9 in humans
(Fig. 2G).
Together, these results show that DHS-3, DHS-4 and DHS-19 are
localized on LDs in diﬀerent tissues. Furthermore, for DHS-9, the tar-
geting probably extends to nuclear LDs in the intestine of C. elegans
(Fig. 2H) but a deﬁnite answer will require more sensitive tests in the
future.
3.5. LD targeting of DHS-3 and 17β-HSD11 is retained in divergent
eukaryotic organisms
We next examined whether LD targeting of 17β-HSD proteins was
broadly conserved. First, the subcellular localization of DHS-3 in HeLa
cells and that of 17β-HSD11 in C. elegans was determined. DHS-3-GFP
was transfected in HeLa cells and the protein showed perfect colocali-
zation with LDs (Fig. 3Aa). Next, transgenic C. elegans that expressed
17b-HSD11 under the control of an intestinal-speciﬁc promoter was
Fig. 1. 17β-HSD11 family proteins were localized on
LDs of bacteria, C. elegans and mammalian cells.
(A) 17β-HSD11 family members have similar pre-
dicted structural features and sequences. This car-
toon compares the structures of six members of the
17β-HSD11 family. From top to bottom, the se-
quences are ABG97784.1 from Rhodococcus jostii,
Q05016.1 from Saccharomyces cerevisiae,
NP_001122508.1 from Caenorhabditis elegans,
NP_001260655.1 from Drosophila melanogaster,
Q9EQ06.1 from Mus musculus and Q8NBQ5.3 from
Homo sapiens. The secondary structural elements are
predicted using Psipred. α-helices are indicated with
cylinders, and β-strands with arrows. The Gly-X3-
Gly-X-Gly motif, Ser (S), Tyr (Y), and Lys (K) residues
are labeled. Substrate binding site regions, active site
regions and NAD(P) binding site regions as predicted
in NCBI are indicated. The percent identities re-
present the alignment of each sequence with
Q8NBQ5.3 from Homo sapiens using blast in NCBI.
(B) (a) Confocal microscopy images of LD localiza-
tion of ro01416-GFP in RHA1, DHS-3::GFP in C.
elegans and 17β-HSD11-GFP in HeLa cells. The green
ring-like structures are due to LD targeting of these
three GFP fusion proteins. LDs were stained by
LipidTOX (red). Scale bar, 5 μm. Enlarged images:
scale bar, 1 μm. (b) ro01416-GFP-expressing bac-
teria, wild type C. elegans and HeLa cells were frac-
tionated and proteins from isolated lipid droplets
(LD), cytosol (Cyto), total membrane (TM), post-nu-
clear supernatant (PNS) and whole cell lysates (WCL)
were separated by 10% SDS-PAGE followed by silver
staining or were analyzed by Western blotting with
anti-GFP, anti-DHS-3 and anti-17β-HSD11, sepa-
rately. (C) This cartoon depicts LD targeting of HSDs
from prokaryotes (bacteria) to eukaryotes (yeast,
worms, insects, mice and humans).
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Fig. 2. HSDs were localized on LDs in
speciﬁc tissues and diﬀerent cellular
structures of individual cells in C. ele-
gans.
(A) Phylogeny of HSDs in LD proteome
of C. elegans, including DHS-3, DHS-4,
DHS-9 and DHS-19. (B) Tissue dis-
tribution of DHS-3, DHS-4 and DHS-
19. Confocal micrographs of expres-
sion patterns of these three proteins in
larval L4 stage animals: dhs-3p::DHS-
3::GFP in the intestine, dhs-4p::DHS-
4::GFP in the hypodermis, and dhs-
19p::DHS-19::GFP in the hypodermis
and muscle as indicated by the arrows.
Scale bar, 5 μm. (C) Cellular distribu-
tion of DHS-9. Fluorescence micro-
graphs of dhs-9p::DHS-9::GFP in larval
L4 stage animals. The upper images:
scale bar, 100 μm. The lower images:
GFP ﬂuorescence in the nucleus is in-
dicated by the arrow. Scale bar, 5 μm.
(D) Micrographs of confocal LSM880
with airyscan showed dhs-9p::DHS-
9::GFP in diﬀerent optical slices from
top to bottom (from left to right, from
upper to lower). It allowed images to
be taken with a higher resolution than
the diﬀraction limit. (E) Confocal mi-
crographs of MDT-28/PLIN-
1::mCherry::NLS and DHS-9::GFP in a
young adult animal. Colocalization of
RFP and GFP signals in the nucleus is
indicated by arrows. Scale bar, 5 μm.
(F) (a) Fluorescence micrographs of
isolated LDs in wild type (1), vha-




mals. Scale bar, 5 μm. Enlarged
images: scale bar, 5 μm. (b)
Quantiﬁcation of images in (a). (G)
Confocal micrographs of LD localiza-
tion of DHS-9 and DHRS1 in Huh7
cells. GFP control, DHS-9-GFP
(NP_498146.1) and DHRS1-GFP
(Q96LJ7.1) were transfected into
Huh7 cells with OA (+OA) or without
OA (−OA) treatment. LDs were
stained with LipidTOX (red) and the
nucleus by Hoechst (blue). Scale bar,
5 μm. Enlarged images: scale bar,
1 μm. (H) The Cartoon shows HSDs are
localized on LDs in diﬀerent tissues
and on diﬀerent types of LDs. DHS-3,
DHS-4 and DHS-19 (green) are sepa-
rately localized on cytoplasmic LDs in
intestine, hypodermis, hypodermis and
muscle. The human ortholog 17β-
HSD11 (green) was in several tissues,
while 17β-HSD13 was restricted to the
liver. Other 17β-HSDs (purple) were
found in the LD proteomes of diﬀerent
tissues (not yet validated by additional
experimental data). DHS-9 and its
human homolog DHRS1 (orange) are
localized on cytoplasmic LDs and nu-
clear LDs in the intestine of C. elegans
and liver cells of mammals.
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generated. The vha-6p::17β-HSD11::GFP was observed surrounding the
LipidTOX signal in ﬁxed worms (Fig. 3Ab). Together, these results
clearly demonstrate that DHS-3 and 17β-HSD11 can target to LDs in
diverse eukaryotic models.
However, when ro01416-GFP was transfected in C. elegans and HeLa
cells, we only observed diﬀuse GFP in the cytosol. Similarly, when DHS-
3-GFP and 17β-HSD11-GFP were transfected into RHA1 cells, diﬀused
ﬂuorescence patterns were observed (data not shown).
3.6. The N-terminal hydrophobic domains of DHS-3 and 17β-HSD11 are
necessary for their association with LDs
To examine the mechanisms driving LD localization of the 17β-
HSDs in diﬀerent organisms, truncation mutants were prepared based
on their secondary structures. GFP-fusion truncations of DHS-3 (amino
acids 1–51 and 52–307) and that of 17β-HSD11 (amino acids 1–38 and
39–300), as well as their full-length proteins were constructed and then
expressed in HeLa cells. The results showed that the full-length and
1–51 fragment of DHS-3 as well as the full-length and 1–38 fragment of
17β-HSD11 were colocalized with LDs (Fig. 3B). However, the 52–307
fragment of DHS-3 and 39–300 fragment of 17β-HSD11 were restricted
to the cytosol, indicating that the N-termini of these two proteins were
necessary for LD targeting.
A similar experiment was conducted with the bacterial ro01416.
GFP-fusion fragments (amino acids 1–60, 1–223, 61–267, 100–267,
144–267, 197–267 and 224–267) and the full-length protein were
generated and were expressed in RHA1 cells. Analysis by confocal mi-
croscopy showed that the full-length and fragments of 61–267,
100–267, and 144–267 were colocalized with LipidTOX signal, and the
197–267 fragment was partially colocalized with LDs. In contrast, the
1–60, 1–223 and 224–267 fragments were distributed in the cytosol,
indicating that the C-terminus of ro01416 was necessary for its tar-
geting to LDs (Fig. S4a).
The alignment of LD targeting sequences, including C-terminus of
ro01416 (144–267), and N-termini of DHS-3 (1–51) and 17β-HSD11
(1–38), showed that the LD targeting sequences of DHS-3 and 17β-
HSD11 were more similar to each other than either was to the ro01416
C-terminus (Fig. S4b).
3.7. Exogenous expression of DHS-3 and 17β-HSD11 induces LD
aggregation and elevated TAG levels
We next examined the functions of DHS-3 and 17β-HSD11.
Overexpression of DHS-3 in C. elegans induced LD clustering (Fig. 2B).
Examination of a vha-6p::dhs-3::gfp single copy worm showed GFP
signal on relatively dispersed LDs. We speculate that the expression
Fig. 3. DHS-3 and 17β-HSD11 targeted to LDs in diverse eu-
karyotic organisms, and N-terminal hydrophobic domains
were necessary for their association with LDs.
(A) Confocal micrographs showing LD localization of DHS-3-
GFP in HeLa cells (a) and 17β-HSD11::GFP in C. elegans (b).
DHS-3-GFP was transfected into HeLa cells and vha-6p::17β-
HSD11::GFP transgenic animals were generated. LDs were
stained by LipidTOX (red). Scale bar, 5 μm. Enlarged images:
scale bar, 1 μm. (B) LD targeting sequences of DHS-3 and 17β-
HSD11. Truncations of DHS-3 (a) and 17β-HSD11 (b) were
made based on secondary structure predictions (α helices
indicated with blue vertical lines; β strands with red vertical
lines and β turns with light green vertical lines). Constructs
coding for the full length proteins and truncations of DHS-3
and 17β-HSD11 were fused with GFP, expressed in HeLa cells
and co-imaged with LipidTOX red staining using confocal
microscopy. Scale bar, 5 μm. Enlarged images: scale bar, 1 μm.
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level of DHS-3 in various strains could aﬀect LD distribution. To further
explore this possibility, dhs-3p::DHS-3::Flag was exogenously expressed
in the dhs-3 single copy transgenic worm (Fig. S5a), resulting in
strongly clustered LDs (Fig. 4A).
Based on this ﬁnding, we investigated whether 17β-HSD11 would
induce a similar phenotype in mammalian cells. Expression of 17β-
HSD11::FLAG was expressed in HeLa cells (Fig. S5b) induced LD
clustering, in contrast to control cells that expressed GFP (Fig. 4Ba). In
addition, TAG assay showed there was a notable increase in TAG con-
tent in 17β-HSD11::FLAG-overexpressing cells (Fig. 4Bb).
We next tested whether these proteins had evolutionarily conserved
ability to induce LD clustering. DHS-3::FLAG was overexpressed in in
HeLa cells, which resulted in clear LD clustering and elevated TAG
content (Fig. 4C, Fig. S5c). Similarly, 17β-HSD11::GFP induced LD
Fig. 4. Overexpression of DHS-3 and 17β-HSD11 induced LD aggregation and TAG accumulation. Catalytic site mutants also induced these phenotypes.
(A) vha-6p::dhs-3::gfp and vha-6p::dhs-3::gfp; dhs-3p::dhs-3::ﬂag (a) animals were generated and visualized by confocal microscopy. Scale bar, 5 μm. Enlarged images:
scale bar, 1 μm. (B) (a) GFP control and 17β-HSD11-FLAG were transfected into HeLa cells which were stained with LipidTOX red and were visualized by confocal
microscopy. Scale bar, 5 μm. Enlarged images: scale bar, 1 μm. (b) TAG content normalized to total protein was quantiﬁed. Data are presented as mean ± SEM.,
n= 3. **P < 0.01, Two-way ANOVA. (C) (a) GFP control and DHS-3-FLAG were transfected into HeLa cells which were stained with Hoechst and LipidTOX red and
were visualized by confocal microscopy. Scale bar, 5 μm. Enlarged images: scale bar, 1 μm. (b) TAG content normalized to total protein was quantiﬁed. Data
presented as mean ± SEM., n= 3. **P < 0.05, two-tailed t-test. (D) vha-6p::17β-HSD11::gfp transgenic animals were constructed and examined by confocal mi-
croscopy. Scale bar, 10 μm. Enlarged images: scale bar, 1 μm. (E) Transgenic animals with dhs-3p::DHS-3 (S175A)::GFP and dhs-3p::DHS-3 (Y—K188–192
deletion)::GFP were constructed and visualized by confocal microscopy (b). LDs were stained with LipidTOX red (a). Scale bar, 5 μm. Enlarged images: scale bar,
1 μm. (F) GFP control (1), 17β-HSD11-FLAG (2), 17β-HSD11 (GHGIG45-49AAAAA)-FLAG (3), 17β-HSD11 (S172A)-FLAG (4), 17β-HSD11 (YCSSK185-189AAAAA)-
FLAG (5), and 17β-HSD11-FLAG (triple mutants) (6) were transfected in HeLa cells. TAG (b) and CE (c) content normalized to total protein was quantiﬁed. Data
presented as mean ± SEM., n= 3. **P < 0.05, two-tailed t-test. GFP control and 17β-HSD11-FLAG (triple mutants)-overexpressing cells were examined by con-
focal microscopy with LipidTOX staining (a). Scale bar, 5 μm. Enlarged images: scale bar, 1 μm.
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aggregation in C. elegans (Fig. 4D). Collectively, these results reveal that
DHS-3 and 17β-HSD11 regulate LD dynamics with similar mechanisms
in diverse eukaryotic models.
3.8. The catalytic sites of the 17β-HSDs are not involved in their
localization or inﬂuence on LD clustering
The 17β-HSDs belong to the SDR family of enzymes that contain a
variable N-terminal Gly-X3-Gly-X-Gly motif as part of the NAD (P)
binding region and a substrate binding region formed by a catalytic
triad of Ser (S), Tyr (Y), and Lys (K) residues [77]. The sequence
alignment of DHS-3 and 17β-HSD11 showed that these two proteins
possessed the common Gly-rich motif and active site (Fig. 1A). There-
fore, catalytic site mutants of these 17β-HSDs were created and ex-
pressed to determine whether enzymatic activity was involved in their
localization and function.
Both DHS-3 (S175A)::GFP and DHS-3 (Y—K188–192 deletion)::GFP
were found to clearly surround LDs when expressed in C. elegans
(Fig. 4Ea). Interestingly, both DHS-3 (S175A)::GFP and DHS-3 (Y—
K188–192 deletion)::GFP also induced LD clustering in C. elegans si-
milar to that seen with wild type DHS-3::GFP overexpressed worms
(Fig. 4Eb). Similarly, overexpression of 17β-HSD11 (G-G-G45-
49AAAAA)-FLAG, 17β-HSD11 (S172A)-FLAG, 17β-HSD11 (Y—K185-
189AAAAA)-FLAG, and 17β-HSD11 (triple mutants)-FLAG in HeLa cells
resulted in increased TAG and CE content (Fig. 4Fb, Fc, Fig. S5d).
Furthermore, overexpression of 17β-HSD11 (triple mutants)- FLAG was
observed to induce clustered LDs (Fig. 4Fa). Other enzymatic site mu-
tants produced a similar LD aggregation phenotype (data not shown).
Collectively, these results clearly demonstrate that the catalytic sites of
the 17β-HSDs do not participate in their localization or their regulation
of LDs clustering.
3.9. There is no evidence of ro01416 involvement in the regulation of LD
distribution and size in RHA1
We next investigated the ability of ro01416 to inﬂuence LD clus-
tering and size in RHA1. Ro01416-GFP was expressed in RHA1 and the
cells were stained with LipidTOX red. The cells were examined by
confocal microscopy and the ﬂuorescence images showed no apparent
diﬀerences between wild type and the transfected cells (Fig. S6a).
Similar to DHS-3 and 17β-HSD11, ro01416 possesses the common Gly-
rich motif and active site. We expressed ro01416 (S144 deletion)-GFP
and ro01416 (Y—K157–161 deletion)-GFP in RHA1 and processed the
cells for imaging. Both deletion mutants were targeted to LDs and the
LD distribution and size were unchanged from that of the wild type cells
(Fig. S6b). Biochemical analysis conﬁrmed that these two GFP tagged
catalytic site mutants were targeted to LDs (Fig. S6c).
Next, we constructed a ro01416-KO (knock out) strain which was
conﬁrmed by PCR (Fig. S6d, Fig. S6e). There was no change in the size
or distribution of LDs in the knockout cells (Fig. S6f). Furthermore,
there were no diﬀerences in the amount of TAG in ro01416-KO,
ro01416-KO-ro01416-GFP, ro01416-GFP, ro01416-KO-ro01416 (S144
deletion)-GFP or ro01416-KO-ro01416 (Y—K157–161 deletion)-GFP
strains (Fig. S6 g). Therefore, the ro01416 protein does not appear to
have any inﬂuence on the regulation of LD distribution and size.
3.10. Loss of function of DHS-3 down regulates fat storage
As DHS-3 and 17β-HSD11 have been determined to induce LD ag-
gregation, we undertook a functional study using deletions mutants. We
leveraged the genetic tractability of C. elegans to examine the pheno-
type of dhs-3 mutants. Previous studies showed a clear decrease in LD
size in dhs-3 (gk873395) mutants [75]. For our study we examined dhs-
3 (tm6151) which deleted 547 bp stretching from the promoter region
to the second exon (Fig. S7a). The patterns of LD-associated proteins
Fig. 5. DHS-3 knock out caused a decrease in LD size and TAG
content.
(A) L4 worms of wild type and dhs-3 mutants were ﬁxed and
stained with LipidTOX. Scale bar, 5 μm. (b) The diameters of
stained LDs were quantiﬁed. Data represent mean ± SEM.
n=20. ***P < 0.0001, two-tailed t-test. (c) TAG content
normalized to total protein was quantiﬁed. Data presented as
mean ± SEM., n=3. **P < 0.05, two-tailed t-test.
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from the mutants and wild type animals were compared by silver
staining and Western blotting. A 36 kDa band present in the wild type
LD protein extract was absent in the dhs-3 deletion mutants. Western
blotting conﬁrmed knockout of DHS-3 in the mutants (Fig. S7b, Fig.
S7c).
To examine the eﬀects of DHS-3 knockout on LD distribution and
size, dhs-3 mutants and wild type animals were ﬁxed with paraf-
ormaldehyde and stained by LipidTOX red. The ﬂuorescence images
were used to quantify LD size. The LDs in dhs-3 mutants were sig-
niﬁcantly smaller than those in wild type animals (Fig. 5A, B). In ad-
dition, there was an obvious reduction of TAG content in dhs-3 mutants
(Fig. 5C). LDs were puriﬁed from dhs-3 mutants and wild type animals
which were then stained by LipidTOX red. The size of LDs from dhs-3
mutants was decreased compared with wild type (Fig. S8a). The size of
the isolated LDs was measured by a Delsa Nano C particle analyzer. By
this analysis the mean LD diameter of dhs-3 mutants was smaller than
that of wild type (Fig. S8b). The results were consistent with our pre-
vious work in dhs-3 (gk873395) mutants [75].
3.11. DHS-3 regulation of fat storage is not dependent on SBP-1 or SCDs
Next we investigated whether DHS-3 inﬂuenced lipid storage
through lipogenesis or lipolysis pathways. First, the lipogenesis
pathway was investigated. SBP-1, the C. elegans SREBP1c ortholog, is
required for eﬃcient transcription of genes involved in fatty acid
synthesis. Depletion of sbp-1 resulted in signiﬁcantly decreased fat
stores [78]. Therefore, the double knockout strain dhs-3; sbp-1 was
created and the size of LDs was quantiﬁed. The double mutants had
smaller LDs than either single mutant (Fig. S9a, Fig. S9b). There was no
diﬀerence in SBP-1 mRNA level in the dhs-3 mutants (Fig. S9e). There
was no apparent change in nuclear localization of GFP::SBP-1 in ani-
mals treated with dhs-3 RNAi (Fig. S9f). Together, these results suggest
Fig. 6. DHS-3 and 17β-HSD11 aﬀected the localiza-
tion of ATGL on LDs.
(A) (a) mdt-28/plin-1p::mdt-28/plin-1::mCherry; vha-
6p::atgl-1::gfp and dhs-3; mdt-28/plin-1p::mdt-28/plin-
1::mCherry; vha-6p::atgl-1::gfp animals were visua-
lized by confocal microscopy. Scale bar, 10 μm.
Enlarged images: scale bar, 5 μm. (b) Quantiﬁcation
of ATGL-1::GFP ﬂuorescence intensity in (a). Data
represent mean ± s.d., n= 5. ***P < 0.0001, two-
tailed t-test. (c) The percentage of ATGL-1::GFP and
MDT-28/PLIN-1::mCherry colocalization was quan-
tiﬁed. Data represent mean ± s.d., n= 5. ns, no
signiﬁcance. (B) Western blotting analysis showing
increased ATGL-1 targeting to LDs in dhs-3 mutants.
vha-6p::atgl-1::gfp and dhs-3; vha-6p::atgl-1::gfp ani-
mals were collected and fractionated. The fractions
were analyzed by Western blotting, probing with
anti-GFP. MDT-28/PLIN-1, Actin and DHS-3 were
probed as controls. (C) Western blotting analysis
showing decreased ATGL targeting to LDs in 17β-
HSD11-overexpressing HeLa cells. GFP control and
17β-HSD11-overexpressing cells were collected and
fractionated. The distribution of endogenous ATGL
in diﬀerent fractions was analyzed by Western blot-
ting with anti-ATGL. PLIN2 and 17β-HSD11 were
detected as controls. (D) The model of DHS-3 and
17β-HSD11 regulating LD size and distribution and
aﬀecting the localization of ATGL on LDs. In C. ele-
gans, dhs-3 knockout (KO) caused small LDs and in-
creased ATGL-1 protein on LDs. In HeLa cells, over-
expression (OE) of 17β-HSD11 induced LD clustering
and decreased ATGL protein on LDs.
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that DHS-3 inﬂuences lipid storage by a pathway independent of SBP-1.
Three genes, fat-5, fat-6 and fat-7, encode stearoyl-CoA desaturases
(SCDs) in C. elegans and these proteins operate downstream of sbp-1. It
is known that fat-6; fat-7 double mutants accumulate less fat than wild
type [79]. Therefore, we generated a dhs-3; fat-6; fat-7 triple mutants.
The triple mutants had smaller LDs than the fat-6; fat-7 double mutants
(Fig. S9c, Fig. S9d), suggesting that DHS-3 also does not function in the
same pathway as FAT-6 and FAT-7.
3.12. Inactivation of dhs-3 results in small LDs dependent on atgl-1
Since dhs-3 deletion reduced fat storage in the lipid synthesis de-
fective mutants, we suspected that dhs-3 deletion resulted in ac-
celerated lipolysis. Adipose triglyceride lipase (ATGL) is the rate-lim-
iting enzyme for triglyceride catabolism in mammals and C. elegans
[80,81]. The ATGL ortholog in C. elegans is encoded by atgl-1. There-
fore, we knocked down atgl-1 by RNAi in wild type and dhs-3 mutants
and quantiﬁed LD size by LipidTOX red staining. The RNAi resulted in
increased LD size in wild type and signiﬁcantly restored LD size in the
dhs-3mutants (Fig. S10a, Fig. S10b). Next, sbp-1mutants and dhs-3; sbp-
1 double mutants were treated with atgl-1 RNAi. Knockdown of atgl-1
had no eﬀect on LD size in sbp-1 mutants. However, atgl-1 RNAi sig-
niﬁcantly increased LD size in dhs-3; sbp-1 double mutants (Fig. S10c,
Fig. S10d). Together, the data suggest that atgl-1 is involved in the
accelerating lipid metabolism in dhs-3 inactive worms.
3.13. DHS-3 and 17β-HSD11 aﬀect the localization of ATGL on LDs
The mechanism by which ATGL-1 aﬀected lipid storage in dhs-3
mutants was investigated. First, ATGL-1 mRNA level was measured by
RT-PCR to determine if dhs-3 knockout inﬂuenced it. However, the
knockout had no eﬀect on ATGL-1 mRNA level (Fig. S11a). Next,
transgenic ATGL-1::GFP animals were generated in dhs-3 mutants to
determine if the ATLG-1 protein level was altered by dhs-3 knockout.
Fluorescence micrographs showed no clear change in ATGL::GFP pro-
tein levels between wild type and dhs-3 mutants (Fig. S11b).
Furthermore, quantiﬁcation of GFP showed no obvious change in dhs-3
mutants (Fig. S11c). However, Western blotting of ATGL-1::GFP ex-
hibited a slightly increase signal in dhs-3 mutants (Fig. S11d).
The localization of ATGL-1::GFP was investigated. Fluorescence
micrographs showed that the GFP ﬂuorescence on separate LD labeled
by MDT-28/PLIN-1::mCherry increased in dhs-3mutants (Fig. 6Aa, Ab),
but the percentage of ATGL-1::GFP and MDT-28/PLIN-1::mCherry co-
localization in dhs-3 mutants has no signiﬁcant change (Fig. 6Ac).
Moreover, it was found that loss function of DHS-3 led to a signiﬁcant
increase of ATGL-1 on LDs by Western blotting (Fig. 6B). Thus, a loss of
DHS-3 promotes ATGL-1 translocation to LDs.
Overexpression of 17βHSD11, the ortholog of DHS-3 in mammals,
caused LD aggregation similar to that of DHS-3. Thus, we investigated
whether 17β-HSD11 could aﬀect the localization of ATGL on LDs.
Control and 17β-HSD11-overexpressing HeLa cells were fractionated by
diﬀerential centrifugation and the fractions were analyzed by Western
blotting. Exogenous expression of 17β-HSD11 resulted in a reduction of
ATGL on LDs without changing the localization or abundance of PLIN2
(Fig. 6C). Together, these results reveal that DHS-3 and 17β-HSD11
regulate LD size and distribution in a similar manner, possibly through
the modulation of ATGL recruitment to LDs (Fig. 6D).
3.14. Loss of function of DHS-3 aﬀects the progeny and growth rates of
worms with a defect in fat synthesis
DHS-3 and 17β-HSD11 clearly have signiﬁcant inﬂuence on LD size,
LD distribution and lipid metabolism. We were interested in de-
termining what larger physiological roles these proteins play at the
organismal level. C. elegans is a good model for physiological function
studies. Therefore, lifespan, L1 survival, hatch rate, progeny and
growth rate of dhs-3 mutants were assessed. However, there were no
signiﬁcant changes compared with wild type (data not shown). It has
been reported that sbp-1 mutants generated fewer progeny and dis-
played growth defects [78]. We found that dhs-3; sbp-1 double mutants
produced fewer progeny and had slower growth than the single mutants
(Fig. S12a, Fig. S12b). In addition, loss function of DHS-3 further re-
duced progeny production and slowed the growth of fat-6; fat-7 double
mutants (Fig. S12c, Fig. S12d). Therefore, DHS-3 impacts progeny and
growth rate in worms containing a defect in fat synthesis.
4. Discussion
4.1. HSDs localize on LDs in diﬀerent organisms, diﬀerent tissues and cell
types, as well as LDs in cytosol and nucleus, and diﬀerent cytoplasmic LD
subsets
In our study, we have summarized the majority of available LD
proteomic data. Several SDRs and a subset of HSDs, the 3β-HSDs, 11β-
HSDs and 17β-HSDs, have been broadly identiﬁed on LDs across tissues
and organisms, suggesting an ancient role for this family in lipid me-
tabolism. To analyze the relationships among the HSD proteins, data-
sets from 12 organisms covering 37 proteins were summarized (Table
S5). Using this dataset, the Maximum Likelihood tree for orthologous
and paralogous proteins of the HSD family was generated (Fig. S13). It
can be inferred from the tree that HSD proteins have been subjected to
substantial selective pressure resulting in repeated loss and gain of
function mutations. Multiple duplication events and higher level mu-
tations have resulted in a large protein family with members per-
forming diverse functional roles across organisms, tissues, and orga-
nelles.
The involvement of HSD family in LD function can be traced back to
bacteria, demonstrating the ancient origins of this role. In this study,
the HSD protein, ro01416, was identiﬁed on LDs in RHA1. The protein
ENV9, an ortholog of RDH12 in humans, targeted to LDs in S. cerevisiae
[82]. DHS-3 and its paralogs were targeted to LDs in C. elegans, CG2254
was found on LDs in Drosophila [21,83], and 17β-HSD11 and 17β-
HSD13 were localized on mammalian LDs [12,71]. However, as the
available phylogenetic tree is incomplete, it is not possible to draw ﬁrm
conclusions on the evolutionary relationships among the LD-targeted
HSDs.
An evolutionary expansion of the HSD family accompanied in-
creased cellular complexity. The development of organelles and mul-
ticellularity saw increased complexity in expression patterns of the
growing protein family (Fig. 2H). A given LD may have multiple HSDs
and some HSDs can be found in several diﬀerent tissues. In C. elegans,
we found DHS-3, DHS-4 and DHS-19 on LDs in diﬀerent tissues. DHS-3
was expressed in the intestine, the main lipid storage site. DHS-4 was
expressed in hypodermis, and DHS-19 was in the hypodermis and
possibly localized on LDs in the muscle. In humans, 17β-HSD11 was
targeted to LDs in epithelium, skeletal muscle, liver, intestine and other
tissues. However, 17β-HSD13, which was very similar to 17β-HSD11,
exhibited liver-speciﬁc expression [42]. The other 17β-HSDs (labeled
by purple in Fig. 2H) were reported to be expressed in several tissues
[84–90]. In the summary of LD proteomes, 17β-HSD2, 17β-HSD4, 17β-
HSD7 and 17β-HSD12 were present on LDs in several tissues. In con-
trast, 17β-HSD6 was present only on liver LDs, and 17β-HSD8 and 17β-
HSD10 were found only in BAT LDs of mice.
In addition to the diﬀerential expression of these proteins across
tissue types, these proteins also vary in their intracellular localization
(Fig. 2H). In eukaryotic cells, neutral lipids are mainly stored in cyto-
plasmic LDs. Recently nuclear LDs were also found in hepatic tissues
and liver cells [76,91,92]. Here, DHS-9::GFP was shown to partially
localize on both cytoplasmic and nuclear LDs in C. elegans. And it was
predominantly on nuclear LDs in the intestinal cells with only a weak
cytoplasmic signal. However, besides the colocalization of MDT-28/
PLIN-1::mCherry::NLS and DHS-9::GFP in the nuclear, it will require
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more sensitive tests to demonstrate that DHS-9::GFP label nuclear LDs
in C. elegans in the future. Following OA treatment, DHS-9 was partially
targeted to both cytoplasmic LDs and nuclear LDs in Huh7 cells, so the
nuclear localization of the GFP-tagged protein may be physiologic. In
humans, DHRS1, the DHS-9 ortholog, could also localize on cyto-
plasmic and nuclear LDs. In our phylogenetic analysis, the DHRS1 fa-
mily had a distant relationship with the other HSD proteins. Other HSDs
are mainly localized on cytoplasmic LDs. For example, DHS-3 is absent
from the nucleus. It is clear that DHRS1 family members can be targeted
to both cytoplasmic and nuclear LDs, and it may be that the nuclear-
targeted proteins have distinct nuclear localization signals (Fig. 2H).
In the cytosol, proteins are targeted to diﬀerent subsets of LDs by an
unknown mechanism. For example, in Drosophila, CG2254 was recently
found on diﬀerent LD subsets as mediated by two distinct targeting
motifs [83]. Together, HSDs could localize on LDs in diﬀerent organ-
isms, tissues and cell types, cytoplasmic and nuclear LDs, as well as
diﬀerent cytoplasmic LDs (Fig. 2H). However, their mechanisms and
functional signiﬁcance of these diﬀering localizations are not clear.
4.2. LD targeting of 17β-HSD proteins
In our study, we found that the related proteins DHS-3 and 17β-
HSD11 were major LD proteins in C. elegans and humans, respectively.
It seems that 17β-HSDs do not form continuous rings in C. elegans, but
are present only on part of the LD periphery in Fig. 3A. This is a
common phenomenon. When ﬁxation and staining are used to visualize
LDs for certain dyes, LD-associated proteins are disturbed dramatically.
In Fig. 4D, it can be seen that 17β-HSDs form continuous ring on in-
dividual LD in C. elegans without ﬁxation.
DHS-3 and 17β-HSD11 targeted to LDs by an N-terminal hydro-
phobic domain and could be appropriately targeted to LDs in diverse
eukaryotic organisms. However, neither was targeted to LDs when ex-
pressed in RHA1, with the proteins showing only a diﬀuse cytoplasmic
distribution. Similarly, ro01416-GFP was found on LDs in RHA1 but
gave only a diﬀuse cytoplasmic distribution when expressed in C. ele-
gans or HeLa cells (data not shown). It is suspected that the eukaryotic
proteins are not folded properly when expressed in bacteria and vice
versa. It is also possible that diﬀerences in LD membrane composition
prevent appropriate targeting. Eukaryotic membranes are rich in
phosphatidylcholine (PC) while prokaryotic membranes are rich in
phosphatidylethanolamine (PE) [93,94]. Our ﬁnding suggests that
ro01416 targets to adiposomes ineﬃciently compared with the other
proteins may be due to the adiposomes construction with PC.
It is known that the hydrophobic N-termini of DHS-3 and 17β-
HSD11 and the hydrophobic C-terminus of ro01416 are required for LD
targeting. However, no more details are known and there is no known
common targeting motif across HSD family proteins. It has been re-
ported that the sequence adjacent to the N-terminal hydrophobic do-
main in 17β-HSD11 had a weak homology with the PAT motif. And
both of them are suﬃcient for ER localization with LDs and LD locali-
zation of 17β-HSD11 [95]. Thus, it remains unknown if LD targeted
proteins like the HSDs, the PAT family, and APO-like proteins share a
common targeting mechanism [96].
4.3. 17β-HSD11 family proteins regulate LD distribution and size in C.
elegans and human cells
Overexpression of DHS-3 and 17β-HSD11 was found to cause LD
aggregation in C. elegans and HeLa cells. It is similar to that over-
expression of AUP1 induces LD clustering in COS7 cells. The CUE do-
main of AUP1, the ubiquitin-binding domain, is not involved in LD
localization of AUP1, but is important for LD clustering [97]. Whereas
the protein enzymatic sites of DHS-3 and 17β-HSD11 were not involved
in the LD targeting or in the LD aggregation, which suggests that these
two proteins promote LD distribution with a diﬀerent underlying me-
chanism. This was consistent with the previous ﬁnding that the
enzymatic activity of CG2254 is not a strict requirement for its LD
subset location [83]. In contrast, it has been reported that over-
expression of Env9 led to the formation of fewer, larger LDs and that
Env9 oxidoreductase activity was essential for this eﬀect [82], which
highlights the diversity and complexity of SDRs on LDs. Overexpression
of DHS-3 and 17β-HSD11 also induced TAG accumulation in HeLa cells
but not in C. elegans, suggesting other HSDs may serve to regulate TAG
accumulation in C. elegans.
In other experiments, a reduction in LD-associated ATGL was seen in
17β-HSD11-overexpressing cells. Knock out of DHS-3 resulted in small
LDs, decreased TAG, and increased ATGL on LDs. These results indicate
that DHS-3 and 17β-HSD11 may aﬀect lipid through the regulation of
lipolysis. The increased lipolysis in dhs-3 mutants aﬀected the lipid
content, brood size, and growth rate in worms that are defective in
lipogenesis. The SDRs were known to function as dimmers and tetra-
mers [77]. Therefore, DHS-3 and 17β-HSD11 may form oligomers
which form a protective layer on LDs, and the possible interaction be-
tween the proteins on diﬀerent LDs may promote LD aggregation.
However, further work is needed to elucidate the detailed mechanisms
by which LD-localized HSDs inﬂuence LD size, distribution and func-
tion. And whether DHS-3 and 17β-HSD11 function as enzymes in other
cellular processes and the functional signiﬁcance of LD localization for
the other HSD proteins remain unknown.
Both of dhs-3 (tm6151) and dhs-3 (gk873395) were separately back-
crossed for 6 times, and small LDs were observed in these two alleles.
Besides, the dhs-3 RNAi showed decreased LD size. Further, like the
phenotypes in dhs-3; sbp-1 mutants, dhs-3 RNAi also enhanced the de-
fect of lipid, brood size and growth rate in sbp-1 mutants (data not
shown). These results veriﬁed that loss of dhs-3 caused small LDs. In the
rescue of small LDs in dhs-3 (tm6151) mutants, the expression of DHS-3
(isoform a)::GFP, fosmid containing dhs-3 gene, and dhs-3 genomic DNA
(extrachromasomal arrays) showed no rescue. The single copy hjSi224
also cannot rescue (data not shown). We suspect that the expression
level of DHS-3 is not well control although the single copy is already
low expressed. It needs further investigation.
4.4. Ro01416 has no signiﬁcant role in LD regulation
Ro01416, an ortholog of human 17β-HSD12, was identiﬁed on LDs
in RHA1. Overexpression of ro01416-GFP had no signiﬁcant eﬀects on
LD size or distribution. Also, LD size and TAG content were unchanged
in ro01416 knock out cells. The possible reasons may include the fol-
lowing: 1) LD dynamics is diﬃcult to observe in RHA1 due to their
small size; 2) ro01416, although targeted to LDs, has a distinct function
from its presumed orthologs, not impacting LD dynamics. It may be that
ro01416 is one of a set of LD-associated HSDs which are not major LD
proteins, unlike DHS-3 and 17β-HSD11. It may be that LD targeting of
HSDs in ancient cell types serves other functions like signaling while
having no roles in regulation of LD size or lipid storage. Perhaps the
other roles of this class of protein evolved over time with the increased
complexity of the cells and the functions of LDs.
4.5. These ﬁndings contribute to LD studies
From prokaryotes to mammals, a large number of HSDs have been
identiﬁed to localize on LDs. These proteins serve not only as excellent
LD markers but also provide a new perspective on the study of LD
evolution and diversity. These enzymes will likely be found to have
important roles in lipid metabolism and LD regulation.
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